Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two

Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two decreased by 16.7% to $5M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two shows a downward trend with a -8.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryEfficiency

SignalHigher is better

VolatilityStable

First reportedQ4 2023

Last reportedQ4 2025Feb 13, 2026

How to read this metric

Consistent or increasing receipts suggest stable long-term support for retiree benefit costs.

Detailed definition

This represents the expected cash inflows from government subsidies related to prescription drug benefits provided under...

Peer comparison

Standard disclosure for companies with significant legacy retiree healthcare liabilities.

Metric ID: other_prescription_drug_subsidy_receipts_year_two1

Historical Data

3 periods

	Q4 '23	Q4 '24	Q4 '25
Value	$6M	$6M	$5M
QoQ Change	—	+0.0%	-16.7%
YoY Change	—	+0.0%	-16.7%

Range$5M – $6M

Avg YoY Growth-8.3%

Median YoY Growth-8.3%

Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two at Other Companies

CF IndustriesCF View metric

AmerenAEE View metric

CF IndustriesCF View metric

Frequently Asked Questions

What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two?: Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, year two of $5M in Q4 2025.
What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two?: Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two has grown at a -8.7% compound annual growth rate (CAGR), from $6M to $5M.
What does defined benefit plan, expected future prescription drug subsidy receipt, year two mean?: Expected government payments for retiree prescription drug costs in the second year.